Bergstrom Donald A
Officer at RLAY
- Sold, on record
- $12.3M
- Dollars the filings state
- Form 4 sales
- 53
- Latest Nov 18, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RLAYRelay Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale RLAYUnusualJan 28 2026
Sold 21,581 shares at $7.72 ($167k)
Bergstrom Donald A, President, R&D
No 10b5-1 planSold 4.9% of holdings ($3.4M position)420,047 shares left8x usual sizeFiling
- 2 Form 4 sale RLAYNo planApr 28 +90 days
Sold 1,490 shares at $14.79 ($22k)
Bergstrom Donald A, President, R&D
No 10b5-1 planSold 0.4% of holdings ($6.2M position)418,557 shares left0.6x usual sizeFiling
- 3 Form 4 sale RLAYUnusualJun 22 +55 days
Sold 93,456 shares at $16.94 ($1.6M)
Bergstrom Donald A, President, R&D
10b5-1 planSold 18.3% of holdings ($8.7M position)418,557 shares left34.7x usual sizeFiling
- 4 Form 4 sale RLAYRoutineJul 6 +14 days
Sold 8,660 shares at $18.71 ($162k)
Bergstrom Donald A, President, R&D
10b5-1 planSold 2.1% of holdings ($7.8M position)409,897 shares left0.7x usual sizeFiling
- 5 Form 4 sale RLAYNo planJul 28 +22 days
Sold 2,237 shares at $18.61 ($42k)
Bergstrom Donald A, President, R&D
No 10b5-1 planSold 0.5% of holdings ($7.6M position)407,660 shares left0.3x usual sizeFiling
- 6 Form 4 sale RLAYRoutineSep 8 +42 days
Sold 8,530 shares at $18.97 ($162k)
Bergstrom Donald A, President, R&D
10b5-1 planSold 2.1% of holdings ($7.7M position)399,130 shares left1x usual sizeFiling
- 7 Form 144 notice RLAYNoticeNov 18 +71 days
Filed to sell 10,269 shares ($169k)
Bergstrom Donald A, Officer
10b5-1 plan0.7x usual sizeFiling
- 8 Form 4 sale RLAYRoutineNov 18 same day
Sold 10,269 shares at $16.51 ($170k)
Bergstrom Donald A, President, R&D
10b5-1 planSold 2.6% of holdings ($6.6M position)386,609 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (54)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2026 | RLAY | President, R&D | Form 4 sale | 10,269 | $170k | 2.6% | Routine | SEC |
| Nov 18, 2026 | RLAY | Officer | Form 144 notice | 10,269 | $169k | Notice | SEC | |
| Sep 8, 2026 | RLAY | President, R&D | Form 4 sale | 8,530 | $162k | 2.1% | Routine | SEC |
| Jul 28, 2026 | RLAY | President, R&D | Form 4 sale | 2,237 | $42k | 0.5% | No plan | SEC |
| Jul 6, 2026 | RLAY | President, R&D | Form 4 sale | 8,660 | $162k | 2.1% | Routine | SEC |
| Jun 22, 2026 | RLAY | President, R&D | Form 4 sale | 93,456 | $1.6M | 18.3% | Unusual | SEC |
| Apr 28, 2026 | RLAY | President, R&D | Form 4 sale | 1,490 | $22k | 0.4% | No plan | SEC |
| Jan 28, 2026 | RLAY | President, R&D | Form 4 sale | 21,581 | $167k | 4.9% | Unusual | SEC |
| Oct 28, 2025 | RLAY | President, R&D | Form 4 sale | 30,897 | $225k | 5.6% | Unusual | SEC |
| Jul 29, 2025 | RLAY | President, R&D | Form 4 sale | 30,770 | $113k | 5.3% | Unusual | SEC |
| Apr 30, 2025 | RLAY | President, R&D | Form 4 sale | 31,562 | $95k | 5.1% | Unusual | SEC |
| Mar 27, 2025 | RLAY | President, R&D | Form 4 sale | 986 | $3k | 0.2% | No plan | SEC |
| Jan 30, 2025 | RLAY | President, R&D | Form 4 sale | 80,450 | $362k | 11.6% | Unusual | SEC |
| Dec 27, 2024 | RLAY | President, R&D | Form 4 sale | 657 | $3k | 0.1% | No plan | SEC |
| Oct 28, 2024 | RLAY | President, R&D | Form 4 sale | 2,688 | $16k | 0.5% | No plan | SEC |
| Sep 27, 2024 | RLAY | President, R&D | Form 4 sale | 648 | $5k | 0.1% | No plan | SEC |
| Jul 29, 2024 | RLAY | President, R&D | Form 4 sale | 2,698 | $24k | 0.5% | No plan | SEC |
| Jun 27, 2024 | RLAY | President, R&D | Form 4 sale | 648 | $4k | 0.1% | No plan | SEC |
| Apr 29, 2024 | RLAY | President, R&D | Form 4 sale | 2,686 | $17k | 0.5% | No plan | SEC |
| Mar 27, 2024 | RLAY | President, R&D | Form 4 sale | 765 | $6k | 0.1% | No plan | SEC |
| Jan 29, 2024 | RLAY | President, R&D | Form 4 sale | 3,178 | $31k | 0.6% | No plan | SEC |
| Dec 27, 2023 | RLAY | President, R&D | Form 4 sale | 977 | $11k | 0.4% | No plan | SEC |
| Oct 30, 2023 | RLAY | President, R&D | Form 4 sale | 3,451 | $21k | 1.4% | No plan | SEC |
| Sep 27, 2023 | RLAY | President, R&D | Form 4 sale | 648 | $5k | 0.3% | No plan | SEC |
| Jul 28, 2023 | RLAY | President, R&D | Form 4 sale | 2,683 | $32k | 1.1% | No plan | SEC |
| Jun 27, 2023 | RLAY | President, R&D | Form 4 sale | 647 | $8k | 0.3% | No plan | SEC |
| Apr 28, 2023 | RLAY | President, R&D | Form 4 sale | 1,383 | $15k | 0.6% | No plan | SEC |
| Mar 27, 2023 | RLAY | President, R&D | Form 4 sale | 763 | $12k | 0.3% | No plan | SEC |
| Jan 30, 2023 | RLAY | President, R&D | Form 4 sale | 1,429 | $31k | 0.6% | Plan not stated | SEC |
| Dec 27, 2022 | RLAY | President, R&D | Form 4 sale | 980 | $14k | 1.1% | Plan not stated | SEC |
| Nov 1, 2022 | RLAY | President, R&D | Form 4 sale | 9,817 | $221k | 10.2% | Plan not stated | SEC |
| Oct 3, 2022 | RLAY | President, R&D | Form 4 sale | 8,000 | $179k | 8.3% | Plan not stated | SEC |
| Sep 27, 2022 | RLAY | President, R&D | Form 4 sale | 976 | $22k | 1.1% | Plan not stated | SEC |
| Sep 8, 2022 | RLAY | President, R&D | Form 4 sale | 25,000 | $750k | 21.8% | Plan not stated | SEC |
| Sep 2, 2022 | RLAY | President, R&D | Form 4 sale | 4,900 | $125k | 5.2% | Plan not stated | SEC |
| Sep 1, 2022 | RLAY | President, R&D | Form 4 sale | 8,100 | $187k | 8.3% | Plan not stated | SEC |
| Aug 24, 2022 | RLAY | President, R&D | Form 4 sale | 15,000 | $375k | 14.3% | Plan not stated | SEC |
| Aug 5, 2022 | RLAY | President, R&D | Form 4 sale | 8,000 | $160k | 8.2% | Plan not stated | SEC |
| Jul 28, 2022 | RLAY | President, R&D | Form 4 sale | 1,835 | $39k | 2.0% | Plan not stated | SEC |
| Jul 6, 2022 | RLAY | President, R&D | Form 4 sale | 8,000 | $160k | 8.0% | Plan not stated | SEC |
| Jun 27, 2022 | RLAY | President, R&D | Form 4 sale | 8,999 | $180k | 9.0% | Plan not stated | SEC |
| May 2, 2022 | RLAY | President, R&D | Form 4 sale | 14,811 | $366k | 13.8% | Plan not stated | SEC |
| Apr 1, 2022 | RLAY | President, R&D | Form 4 sale | 18,000 | $546k | 16.0% | Plan not stated | SEC |
| Mar 29, 2022 | RLAY | President, R&D | Form 4 sale | 622 | $19k | 0.7% | Plan not stated | SEC |
| Mar 24, 2022 | RLAY | President, R&D | Form 4 sale | 10,000 | $300k | 9.5% | Plan not stated | SEC |
| Mar 10, 2022 | RLAY | President, R&D | Form 4 sale | 10,000 | $250k | 9.5% | Plan not stated | SEC |
| Mar 1, 2022 | RLAY | President, R&D | Form 4 sale | 8,000 | $191k | 7.8% | Plan not stated | SEC |
| Feb 22, 2022 | RLAY | President, R&D | Form 4 sale | 22,994 | $482k | 19.5% | Plan not stated | SEC |
| Dec 27, 2021 | RLAY | Officer | Form 4 sale | 649 | $21k | 1.4% | Plan not stated | SEC |
| Oct 15, 2021 | RLAY | Officer | Form 4 sale | 30,000 | $1M | 39.7% | Unusual | SEC |
| Sep 27, 2021 | RLAY | Officer | Form 4 sale | 646 | $24k | 0.8% | Plan not stated | SEC |
| Jun 28, 2021 | RLAY | Officer | Form 4 sale | 976 | $35k | 1.3% | Plan not stated | SEC |
| Jun 16, 2021 | RLAY | Officer | Form 4 sale | 42,242 | $1.4M | 35.4% | Unusual | SEC |
| Apr 16, 2021 | RLAY | Officer | Form 4 sale | 56,324 | $1.8M | 42.2% | Unusual | SEC |